Skip to main content
. Author manuscript; available in PMC: 2015 Jan 20.
Published in final edited form as: Lancet Oncol. 2009 Dec 18;11(2):136–146. doi: 10.1016/S1470-2045(09)70343-2

Table 4.

Univariate and multivariable Cox regression analysis of disease-free survival*

Univariate analysis
Multivariable analysis
Hazard ratio (95% CI) p Hazard ratio (95% CI) p
Age 1·0 (0·9–1·0) 0·63 ·· ··

Sex
 Men 1·0 (reference) 0·31 ·· ··
 Women 1·3 (0·7–2·5) ··

Histological type
 Intestinal 1·0 (reference) 0·67 ·· ··
 Diffuse 1·1 (0·6–2·1) ··

T
 T1–T2 1·0 (reference) 0·001 ·· ··
 T3–T4 3·1 (1·5–6·1) ··

N
 Negative 1·0 (reference) <0·0001 ·· ··
 Positive 5·5 (2·1–14·2) ··

Stage
 I–II 1·0 (reference) <0·0001 1·0 (reference) <0·0001
 III–IV 4·5 (2·2–9·2) 5·2 (2·4–11·2)

let-7b expression
 High 1·0 (reference) 0·003 1·0 (reference) 0·001
 Low 2·7 (1·4–5·4) 3·2 (1·6–6·6)

let-7g expression
 High 1·0 (reference) 0·002 1·0 (reference) 0·042
 Low 2·7 (1·4–5·2) 2·0 (1·0–3·9)

miR-19a expression
 High 1·0 (reference) 0·032 1·0 (reference) <0·0001
 Low 2·0 (1·0–3·6) 3·3 (1·7–6·5)

miR-495 expression
 Low 1·0 (reference) 0·035 1·0 (reference) 0·007
 High 1·9 (1·0–3·6) 2·4 (1·2–4·7)

miR-410 expression
 Low 1·0 (reference) 0·016 ·· ··
 High 2·2 (1·1–4·3) ··

miR-433 expression
 High 1·0 (reference) 0·011 ·· ··
 Low 2·1 (1·1–4·0) ··
*

No patients were censored before first event (disease recurrence).

For the final model of multivariable analysis, stage, let-7b, let-7g, miR-19a, and miR-495 were included.